Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
seekingalpha.com » Biotech Sector and Stocks Analysis from Seeking Alpha - Feb 11, 2010
ZymoGenetics, Inc. (ZGEN) Q4 2009 Earnings Call February 11, 2010 04:30 pm ET Complete Story »
bizjournals.com » Seattle Business News - Local Seattle News | The Puget Sound Business Journal - Feb 11, 2010
ZymoGenetics Inc. reported fourth-quarter net income of $13.6 million, or earnings of 19 cents per diluted share, compared with a net loss of $9.2 million, or a loss of 13 cents per share a year earlier. (ZGEN)
streetinsider.com » StreetInsider.com News Articles - Jan 19, 2010
UPGRADES: J.P. Morgan upgrades ev3 (NASDAQ: EVVV) from Neutral to Overweight. Price target increased from $15 to $19. Credit Suisse upgrades Ciena (NASDAQ: CIEN) from Neutral to Outperform. RBC Capital upgrades JDS …
Also tagged: s, jdsu, x, svu, cien, imax, biib, jaso, aks, evvv, paet, peb
streetinsider.com » StreetInsider.com News Articles - Jan 19, 2010
Visit StreetInsider.com at http://www.streetinsider.com/New+Coverage/Leerink+Swann+Starts+ZymoGenetics+%28ZGEN%29+at+Outperform%2C+%248+Price+Target/5254966.html for the full story.
streetinsider.com » StreetInsider.com News Articles - Jan 7, 2010
Bakers Footwear Group, Inc. (NASDAQ: BKRS) 85.1% HIGHER; today reported December 2009 sales. For December, the five-week period ended January 2, 2010, net sales increased to $30.0 million, compared to $27.4 million in …
Also tagged: gme, zigo, insp, tsra, cbk, iivi, cycc, bkrs, prxi, citp, sutr
streetinsider.com » StreetInsider.com News Articles - Dec 21, 2009
ZymoGenetics, Inc. (NASDAQ: ZGEN) 9% LOWER; today announced a restructuring of the U.S. co-promotion and ex-U.S. license and collaboration agreements with Bayer Schering Pharma AG and Bayer HealthCare relating to …
Also tagged: byd, ceph, lly, ttwo, snx, jbl, pdli, jsda, clrt, trv
seekingalpha.com » Biotech Sector and Stocks Analysis from Seeking Alpha - Dec 14, 2009
The Burrill Report submits: by MARIE DAGHLIAN Celgene (CELG) beefed up its blood cancer pipeline with the acquisition of privately-held Gloucester Pharmaceuticals for $340 million in cash plus $300 million in future …
Also tagged: msft, gsk, nvo, sny, celg, isis, lly, sgen, ccm, rhhby pk, cytk, aliof pk, gnmsf pk, the burrill report, nkbp
seekingalpha.com » Biotech Sector and Stocks Analysis from Seeking Alpha - Dec 14, 2009
The Burrill Report submits: Cytokinetics (CYTK) and GlaxoSmithKline (GSK) agreed to terminate their eight-year collaboration and license agreement on cancer drugs. The termination is effective February 28, 2010. As a …
Also tagged: gsk, somx, rhhby pk, rgen, cytk, ugne ob, aliof pk, the burrill report, tsma
bizjournals.com » Seattle Business News - Local Seattle News | The Puget Sound Business Journal - Nov 23, 2009
Bruce Carter, who headed Seattle biotech ZymoGenetics Inc. from 1998 to January of this year, has been named executive chairman and director of Immune Design Corp. (ZGEN)
streetinsider.com » StreetInsider.com News Articles - Nov 6, 2009
NightHawk Radiology Holdings, Inc. (NASDAQ: NHWK) 26% LOWER; reports Q3 EPS of $0.17, ex-items, 1 cent better than the analyst estimate of $0.16. Revenue for the quarter was $43.5 million, which compares to the …
Also tagged: move, sam, tasr, hans, crox, rail, acls, arp, mfw, cstr, lgnd, lpsn, rrgb, nhwk, wg, gsi, rocm, bx, ocnw, cvm, ziop, gok, grt, cvi, abr, cabl